Global Liver Institute

Web Releases

GLOBAL LIVER INSTITUTE

Web Releases
ICER Midwest CEPAC Works to Keep Up with Well-Informed NASH Patient Advocates

ICER Midwest CEPAC Works to Keep Up with Well-Informed NASH Patient Advocates

On Friday, the Institute for Clinical and Economic Review (ICER) held a public hearing to review its draft assessment of Resmetirom and Obeticholic Acid (OCA) for Non-Alcoholic Steatohepatitis: Effectiveness and Value. While the evidence presented for both drugs was deemed effective in fibrosis regression, ICER inconsistently voted to show that there was only a net health benefit in favor of resmetirom, being superior to lifestyle management alone, and not in OCA.

read more
Public Witness Testimony, Donna Cryer

Public Witness Testimony, Donna Cryer

GLI CEO Donna R. Cryer addresses the concerns of the liver disease community about the senseless rising incidence of liver disease and liver cancers when measures to prevent, diagnose, and treat liver disease and liver cancer are available.

read more
Obstetric and Neonatal Professionals Must Work More Closely with Pregnant People to Identify Liver Diseases Early

Obstetric and Neonatal Professionals Must Work More Closely with Pregnant People to Identify Liver Diseases Early

(Washington D.C., February 1, 2023) – Global Liver Institute (GLI) launches its third annual #RareAware campaign today to raise awareness of and build resources for liver health challenges to maternal and neonatal well-being through a series of webinars, storytimes, and social media outreach. Liver diseases such as (spell out) ICP and BA can complicate a pregnancy or endanger a newborn’s earliest days, in the worst cases threatening the lives of baby and mother alike.

read more
Global Liver Institute Announces New Leadership of the Liver Action Network

Global Liver Institute Announces New Leadership of the Liver Action Network

In 2021, Global Liver Institute (GLI) launched the Liver Action Network (LAN) to better synchronize engagement across the liver advocacy community and to meet the needs of a rapidly growing cadre of liver health advocates. The LAN operates as a first-of-its-kind network that provides community member organizations a central structure for the formulation of collective health policy and programmatic solutions.

read more
If We Do Not Prevent Liver Disease Now, the World Will Face Devastating Loss of Both Life and Financial Resources

If We Do Not Prevent Liver Disease Now, the World Will Face Devastating Loss of Both Life and Financial Resources

Global Liver Institute (GLI), the premier patient-led liver health nonprofit operating globally, announces the launch of its Global State of Liver Health report as part of its Liver Health is Public Health (LHPH) initiative. Through compiled statistics and expert perspectives, the report paints a preliminary picture of the key issues in liver health worldwide as well as the unique challenges faced by communities in specific regions before providing recommendations for the future.

read more